Agile Therapeutics, Inc. (AGRX)

Last Closing Price: 0.60 (2024-03-25)

Receiveable Turnover (Annual)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Agile Therapeutics, Inc. (AGRX) had Receiveable Turnover of 5.78 for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$19.59M
$-14.46M
$8.98M
$10.62M
$39.48M
$-19.88M
$5.42M
$-14.46M
$-14.46M
$-14.46M
$-14.46M
$-14.46M
$-14.46M
$-19.88M
$-18.43M
2.16M
2.16M
$-6.71
$-6.71
Balance Sheet Financials
$9.53M
$0.07M
$0.72M
$10.26M
$20.78M
--
$5.80M
$26.57M
$-16.32M
$-16.32M
$-16.32M
2.96M
Cash Flow Statement Financials
$-9.58M
--
$6.89M
$5.25M
$2.56M
$-2.69M
$1.98M
--
--
Fundamental Metrics & Ratios
0.46
--
--
--
-0.10
54.18%
-101.49%
-101.49%
-94.09%
-73.83%
-73.83%
$-9.58M
--
--
--
1.91
3.28
Receiveable Turnover
5.78
63.19
88.64%
88.64%
-141.05%
88.64%
$-5.51
$-4.44
$-4.44